Clinical Trial

First-in-human Study of 7MW4911 in GI Cancer

Name: First-in-human Study of 7MW4911 in GI Cancer — clinical trial record (NCT07216560)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is the first-in-human study of 7MW4911 in US patients, to investigate its prelimary safety and efficacy in patients with gastrointestinal cancers.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-10-10; most recent amendment 2026-04-29.

Status change: Not Yet Recruiting → Recruiting 2026-01-14

Trial Details

NCT Number	NCT07216560
Lead Sponsor	Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions	GI Cancers
Enrollment	200 participants
Start Date	2026-01-13
Primary Completion	2027-07 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-30